Gigantest, Inc

Gigantest Inc. will leverage next-level metabolomics to expose the origin and path of telltale metabolites, providing more precise, detailed, and actionable information than existing solutions to academia and industry in a wide range of sectors, including the food industry, agriculture, biomedical, pharmaceutical, biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and more. Moreover, our state-of-the-art, cutting-edge metabolomics technologies will be used to revolutionize the detection and monitoring of countless diseases such as cancer, cardiovascular disorders, neurological disorders, and inborn errors of metabolism, among many others.